2018 Annual review of diseases prioritized under the Research and Development Blueprint
Description
The second annual review occurred 6-7 February, 2018. Experts consider that given their potential to cause a public health emergency and the absence of efficacious drugs and/or vaccines, there is an urgent need for accelerated research and development for*:Crimean-Congo haemorrhagic fever (CCHF)Ebol